Announcement on Holding Subsidiary Obtaining Drug Registration Certificate
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Holding Subsidiary Obtaining Drug Registration Certificate
Filed with SSE · · 2 pages · Chinese
Release
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Wholly-owned Subsidiary's Drug Substance Obtaining Indian Registration Certificate
- Announcement on Resolutions of the 2025 Annual General Meeting
Later from Shanghai Shyndec Pharmaceutical
- Announcement on Resolutions of the 5th Meeting of the 9th Board of Directors
- Semi-annual Performance Forecast for 2026
- Announcement on the Wholly-owned Subsidiary's Drug Passing Generic Drug Consistency Evaluation
- Announcement on Obtaining Drug Registration Certificate by Wholly-owned Subsidiary
- Announcement on Progress of Signing of the "Drug Marketing Authorization Transfer Contract" by a Controlled Subsidiary
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical